Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial
Manomaipiboon et al., Trials, doi:10.1186/s13063-022-06649-3 (preprint 2/2/2022)
https://c19ivm.org/manomaipiboon.html